Huron closes divestiture of life sciences business to oliver wyman

Chicago--(business wire)--global professional services firm huron (nasdaq: hurn) today announced it has closed the divestiture of its life sciences commercial and r&d strategy, pricing, and market access strategy business to oliver wyman. oliver wyman is a global management consulting firm and a business of marsh mclennan (nyse: mmc). huron will concentrate its resources and investments in strengthening the company's industry expertise and capabilities in healthcare, education and the other
HURN Ratings Summary
HURN Quant Ranking